Bhangu Aneel, Singh Prashant, Fitzgerald J Edward F, Slesser Alistair, Tekkis Paris
Department of Colorectal Surgery, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK,
World J Surg. 2014 Sep;38(9):2247-57. doi: 10.1007/s00268-014-2531-1.
Enhanced recovery programs following colorectal resection recommend the use of nonsteroidal anti-inflammatory drugs (NSAIDs) as part of multimodal analgesia. The present study aimed to assess whether postoperative NSAID use increased the risk of anastomotic leak.
A systematic review of published literature was performed for studies comparing anastomotic leak following NSAID administration versus control. Meta-analysis was conducted for studies in human patients and experimental animal models. The primary endpoint was anastomotic leak.
The final analysis included 8 studies in humans and 12 experimental animal studies. Use of NSAIDs was significantly associated with anastomotic leak in humans (8 studies, 4,464 patients, odds ratio [OR] 2.14; p < 0.001). This effect was seen with nonselective NSAIDs (6 studies, 3,074 patients, OR 2.37; p < 0.001), but not with selective NSAIDs (4 studies, 1,223 patients, OR 2.32; p = 0.170). There was strong evidence of selection bias from all clinical studies, with additional inconsistent definitions and outcomes assessment. From experimental animal models, anastomotic leak was more likely with NSAID use (ten studies, 575 animals, OR 9.51; p < 0.001). Bursting pressures at day 7 were significantly lower in NSAID versus controls (7 studies, 168 animals, weighted mean difference -35.7 mmHg; p < 0.001).
Emerging data strongly suggest that postoperative NSAIDs are linked to anastomotic leak, although most studies are flawed and may be describing pre-existing selection bias. However, when combined with experimental data, these increasing concerns suggest caution is needed when prescribing NSAIDs to patients with pre-existing risk factors for leak, until more definitive evidence emerges.
结直肠切除术后的加速康复计划建议使用非甾体类抗炎药(NSAIDs)作为多模式镇痛的一部分。本研究旨在评估术后使用NSAIDs是否会增加吻合口漏的风险。
对已发表的文献进行系统回顾,以比较NSAIDs给药后与对照组的吻合口漏情况。对人类患者和实验动物模型的研究进行荟萃分析。主要终点是吻合口漏。
最终分析包括8项人类研究和12项实验动物研究。在人类中,使用NSAIDs与吻合口漏显著相关(8项研究,4464例患者,比值比[OR]2.14;p<0.001)。非选择性NSAIDs可见此效应(6项研究,3074例患者,OR 2.37;p<0.001),但选择性NSAIDs未见此效应(4项研究,1223例患者,OR 2.32;p=0.170)。所有临床研究均有强烈的选择偏倚证据,且存在定义和结局评估不一致的情况。在实验动物模型中,使用NSAIDs更易发生吻合口漏(10项研究,575只动物,OR 9.51;p<0.001)。与对照组相比,NSAIDs组第7天的破裂压力显著更低(7项研究。168只动物,加权平均差-35.7 mmHg;p<0.001)。
新出现的数据强烈表明,术后使用NSAIDs与吻合口漏有关,尽管大多数研究存在缺陷,可能描述的是预先存在的选择偏倚。然而,结合实验数据来看,这些日益增加的担忧表明,在给已经存在吻合口漏风险因素的患者开NSAIDs处方时需要谨慎,直到有更确凿的证据出现。